Mark J. Enyedy
2018
In 2018, Mark J. Enyedy earned a total compensation of $8.8M as President and Chief Executive Officer at ImmunoGen, a 231% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $569,333 |
|---|---|
| Option Awards | $7,558,279 |
| Salary | $686,750 |
| Other | $8,880 |
| Total | $8,823,242 |
Enyedy received $7.6M in option awards, accounting for 86% of the total pay in 2018.
Enyedy also received $569.3K in non-equity incentive plan, $686.8K in salary and $8.9K in other compensation.
Rankings
In 2018, Mark J. Enyedy's compensation ranked 869th out of 14,244 executives tracked by ExecPay. In other words, Enyedy earned more than 93.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 869 out of 14,244 | 94th |
Division Manufacturing | 292 out of 5,762 | 95th |
Major group Chemicals And Allied Products | 88 out of 2,125 | 96th |
Industry group Drugs | 68 out of 1,814 | 96th |
Industry Pharmaceutical Preparations | 47 out of 1,388 | 97th |
Source: SEC filing on April 28, 2020.
Enyedy's colleagues
We found five more compensation records of executives who worked with Mark J. Enyedy at ImmunoGen in 2018.
2018
Richard Gregory
ImmunoGen
Chief Scientific Officer
2018
Craig Barrows
ImmunoGen
General Counsel
2018
Theresa Wingrove
ImmunoGen
Senior Vice President, Regulatory Affairs and Quality
2018
Anna Berkenblit
ImmunoGen
Chief Medical Officer
2018
Thomas Ryll
ImmunoGen